✦ LIBER ✦

High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma

✍ Scribed by Jae Yong Cho; Hyun Cheol Chung; Sung Hoon Noh; Jae Kyung Roh; Jin Sik Min; Byung Soo Kim

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 109 KB
Volume: 79
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19970301)79:5<878::aid-cncr2>3.0.co;2-8

No coin nor oath required. For personal study only.

✦ Synopsis

defined risk factor in patients with gastric carcinoma.

METHODS.

Enzyme-linked immunoadsorbent assays were used to test for uPA anti-

📜 SIMILAR VOLUMES

Urokinase plasminogen activator as a pro

Urokinase plasminogen activator as a prognostic marker in different subgroups of patients with breast cancer

✍ Michael J. Duffy; David Reilly; E. McDermott; Niall O'Higgins; James J. Fennelly 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB 👁 2 views

Elevation of serum levels of urokinase-t

Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer

✍ Miyake, Hideaki; Hara, Isao; Yamanaka, Kazuki; Gohji, Kazuo; Arakawa, Soichi; Ka 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

BACKGROUND. Several investigators have revealed that urokinase-type plasminogen activator (uPA) and its receptor (uPAR) are overexpressed in serum as well as in tumor tissues in patients with various types of cancer. In this study, we examined whether the serum levels of uPA and uPAR could be used a